Stupid RRer thoughts: 1) Quiet period: Means we are

New Post Public Reply Private Reply Replies (0) Message Board
homerbedloe
454
Stupid RRer thoughts:

1) Quiet period:

Means we are actively engaged with the SEC for the pathway to be listed...and more importantly, SEC is actively engaged with NGIO. This indicates we are close to receiving the effective notice needed to register the stock and get us listed. GNBT remaining quiet is a tip of the cap to the SEC process, whether we like it or not.

2) The II-key vaccine work:

We have a vaccine, now we are checking to see if it is a "complete vaccine" from a memory perspective. That will be known in 7 - 10 days. That work is being done at the request of the FDA. The FDA is therefore obviously aware of GNBT's pursuit, and is actively engaged.

The doctors are very confident that the results we are waiting for will be similar to those observed previously (I think it was said 2 or 3 times). The results seen previously are very good indicating the team thinks the near future results will also be very good (thanks RJS for translating RP's discussion - it sounded positive, but to me, it also sounded like it was a foreign language).

We have a booster - regardless of whether the vaccine is complete or not, the work to date can be used as a booster for the existing PFE, Mod and J&J vaccines. My take is that if the memory aspect fails, the targeted neutralizing antibody aspect is already a success, making the GNBT solution better than any existing wide spectrum vaccines that have been developed.

We have a therapeutic. Monoclonal (yes? no? made up word?) antibody (like remdesivir, if I understand the term correctly). So we can vaccinate those that haven't been exposed, improve vaccines from other companies, and if I understand the terminology, treat those that have caught the virus to help them get well. Can any other company say they have those three aspects covered?

Our vaccine uses a sniper rifle instead of a shotgun. The sniper rifle can be used against the main virus, and can be readily modified to hit variants.

The vaccine/booster can be quickly produced in mass quantities and does not need refrigeration for shipping.

We have multiple deals with China (for vaccine and many other aspects of GNBT work) and Malaysia, and we have funding from Malaysia for the vaccine development work in the US. China will do most of the trials in China, and they are expected to expedite those trials so maybe we can piggy back off those results if the protocols meet FDA standards.

If I have misunderstood or misstated any of this, RJS, Doc or any number of other sharp folks on this board will and should correct me.

Finally, I'm not worried about the pps - with that last minute run up on Thursday, it was painfully obvious that there was likely to be selling today unless Joe reported they had SEC effective notice for the registration of the NGIO shares. It seemed to me any update re: just the science or the progression of the development would be met with selling. I hoped it would be less than 25%, but it is what it is and there is no way GNBT could control it.

I expect that next week we will see a small rebound - maybe not back to $.60 but maybe low $.50s. Either way, as the future results come in, the trials begin and the spin off proceeds, the pps should advance. How fast and how far is currently just a guess.

GNBT is not going bankrupt, and will have complete vaccine results in a couple of weeks - which are EXPECTED to be excellent. That is the lead; the rest is the backstory. While the technical issues with the CC affected getting the message out, the message is still damn good.

Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Alabama Power's 2027 Cut Puts Data Centers to Work

Updated Category News Views 107

Data centers rarely arrive bearing a gift for ordinary power customers. Yet Alabama Power says its coming load growth will help cut customer rates by $160 million in 2027, beginning with January bills. In a utility world stuffed with requests for more money, that is a sharp change of pace. The company filed the reduction with the Alabama Public Service Commission on Nov....

Continue Reading
iHeart's 65% Plunge Brings a Fraud Probe Into Focus

Updated Category News Views 71

November 10 did not merely bruise iHeartMedia shareholders; it left the stock closing at $0.61 after a decline of more than 65%. That kind of move gets everybody’s attention, including plaintiffs’ lawyers, and Wolf Haldenstein Adler Freeman & Herz LLP has opened an investigation into potential securities fraud claims involving iHeartMedia, its officers, and its...

Continue Reading
Greenberg Traurig Adds Privacy Muscle in Denver Office

Updated Category News Views 147

Privacy work used to be the legal department's back-room plumbing; now it can jam an entire product launch. That is why Greenberg Traurig's decision to bring Amber Mednick in as of counsel in Denver deserves more attention than the usual law-firm hiring blurb. This is not a splashy deal, and nobody should pretend one lateral hire rewrites the competitive map. Still, it is...

Continue Reading
DISA Backs Nursing Education With OADN Foundation Push

Updated Category News Views 51

A nursing workforce does not appear by magic when hospitals need it most; somebody has to help students, instructors, and programs survive the long haul before that first shift. DISA's newly announced partnership with the Organization for Associate Degree Nursing and the OADN Foundation is aimed squarely at that unglamorous, essential stretch of the pipeline. For a sector...

Continue Reading
Maryland Handgun Ban Suit Puts Ruger in Legal Crossfire

Updated Category News Views 96

A January Deadline With Real Commercial Teeth Maryland has turned a trigger-design dispute into a fresh legal and retail headache, and the clock is not polite about it. The National Shooting Sports Foundation filed suit against the state over S.B. 334, which is scheduled to take effect Jan. 1, 2027. The law bars sales of certain pistols with cruciform trigger bars,...

Continue Reading
Epic Blue Puts $50,000 of Marketing Work to Use Locally

Updated Category News Views 84

A $50,000 pile of donated know-how can look soft on a spreadsheet, until you remember how often a small nonprofit or early-stage outfit gets ignored because it cannot afford someone to sharpen its message. Epic Blue Marketing, a women-owned firm based in Jackson, Michigan, says it provided that amount in donated and reduced-rate marketing, communications and public...

Continue Reading
Employer Ghosting Is a Quiet Talent-Cost Problem Today

Updated Category News Views 39

Silence is cheap right up until a company needs talent again. Then the unanswered email, abandoned interview loop, or vanished promise of next steps comes back with a price tag—maybe not neatly labeled in a quarterly filing, but real all the same. LiveCareer’s April 14, 2026 survey of 1,008 employed U.S. adults lands on an uncomfortable point: candidates remember...

Continue Reading
GIGABYTE Pitches Local AI Agents to Enterprise Buyers

Updated Category News Views 72

Enterprise AI has reached the awkward stage where a slick chatbot demo no longer cuts it. GIGABYTE used its November 13 AI Partner Summit at the Pacific Palms Resort to make a more grounded pitch: companies need hardware and software setups that can put AI agents to work without casually tossing proprietary information into somebody else’s cloud. That is a sensible...

Continue Reading
New York Gala Puts $3 Million Behind EB Research Work

Updated Category News Views 67

Three million dollars changes the temperature in a research room, even if it does not magically solve the hard part. EB Research Partnership said its New York gala raised more than $3 million, with Eddie Vedder, Hozier, Tom Holland and Colin Farrell among the names helping draw attention. For a nonprofit operating around research, that is not a fluffy society-page...

Continue Reading
Avenir Nears 19.99% Grid Stake After Falcon West Resource

Updated Category News Views 76

Falcon West finally put enough geological meat on the bone to make Avenir reach for its wallet. Avenir Minerals expects to buy 29,388,127 Grid Metals common shares on or about November 30, 2026, taking its non-diluted position to 19.99%. That number is not accidental. It is the usual Canadian strategic-investor ceiling before the conversation starts getting considerably...

Continue Reading

Top 5 Most Recently Viewed Articles

Hyundai Unveils Palisade with John Krasinski for Epic Campaign

Updated Category News Views 223

Hyundai Launches 'Make Everyday Epic' Campaign Hyundai is thrilled to announce its latest marketing strategy highlighted by the Palisade Hybrid SUV, a vehicle designed to enrich everyday experiences. With its stunning aesthetics and performance capabilities, the Palisade emerges as a perfect choice for those seeking a touch of luxury in their daily activities. Epic...

Continue Reading
Olympus Corporation Updates Landscape with New CPT Codes

Updated Category News Views 238

Olympus Corporation Introduces New CPT Codes for ESD Olympus Corporation, a pioneering global medical technology company, has taken a significant step towards enhancing patient care in the realm of gastrointestinal health. Recently, the American Medical Association (AMA) announced the establishment of new Category I CPT codes for the Endoscopic Submucosal Dissection (ESD)...

Continue Reading
Audience Town's Conversion-Focused Tool Transforms Home Building

Updated Category News Views 156

Introducing Audience Town's New Tool for Home Builders Audience Town, a pioneering platform in home building performance analytics, has recently launched the Audience Targeting Add-On. This innovative tool marks a significant milestone for builders, providing them with the ability to retarget their highest-value website visitors effectively, effectively eliminating...

Continue Reading
Investor Class Action Alerts: Navigating Recent Legal Developments

Updated Category News Views 182

Investor Class Action Alerts: An Overview In today's marketplace, investors remain vigilant against various legal risks as class action lawsuits emerge against publicly traded companies. These lawsuits can significantly affect shareholders who are often left navigating complex legal landscapes. A recent reminder from The Law Offices of Frank R. Cruz regarding upcoming...

Continue Reading
Elisity’s Texas Water Pilot Puts IonQ’s Deal in View

Updated Category News Views 261

Water-system security is not a place for chest-thumping Elisity’s role in Texas Project Watershed 250 lands on a problem that is painfully concrete: water and wastewater utilities have to keep pumps, treatment systems and plant operations running while trying to close cybersecurity gaps. That is a tougher job than selling another dashboard to a corporate IT department....

Continue Reading